Stay updated on Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Sign up to get notified when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.
Latest website image capture
Clouds background image

Latest updates to the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 to the record history and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T21:26:27.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    A new version entry v3.4.2 was added to the record history, and the previous entry v3.4.1 was removed.
    Difference
    0.1%
    Check dated 2026-02-12T01:40:12.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The history shows an internal release update with the addition of revision v3.4.1 and removal of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:15:10.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added a glossary toggle and color-coded highlights for changes (green for additions, red for deletions) on the history view. A new Revision: v3.4.0 label appears, and the No FEAR Act data entry is removed.
    Difference
    1%
    Check dated 2026-01-28T20:28:39.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The history now shows a new revision entry v3.3.4 and the previous revision v3.3.3 has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:47:53.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The record history now includes a new site release note 'Revision: v3.3.3' and removes the earlier release note 'Revision: v3.3.2' as well as the 'HHS Vulnerability Disclosure' entry from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-23T21:08:14.000Z thumbnail image

Stay in the know with updates to Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib

Enter your email address, and we'll notify you when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.